Regeneron, Roche’s antibody cocktail cuts COVID-19 hospitalizations, deaths by 70%, company says

A combination monoclonal antibody cocktail produced by Regeneron and Roche has shown to reduce hospitalization or death in COVID-19 patients by as much as 70%, a press release posted Tuesday said.